Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

German Government Wants Sildenafil, Tadalafil OTC

Oct 06 2022

• By David Ridley

Related Content

Delay For Sanofi’s OTC Cialis Study In US Could Be Sign of Hurdles Holding Back Other Switches

May 31 2022

Poland’s Adamed Secures Tadalafil Rx-To-OTC Switch In World First

Mar 07 2022

Sanofi Feeling Positive On Cialis Switch Progression As Q2 Sales Rise

Jul 29 2022

Sanofi Starting US Cialis OTC Actual Use Study Soon While Tamiflu Switch Progress Delayed

Apr 29 2022

With OTC <em>Cialis</em> Rights, Sanofi Launches Latest Salvo In Consumer Sector Battle

May 28 2014

Why Did Germany Reject Sildenafil OTC Switch?

Mar 30 2022

Switching Can Help Normalize Self-Care – PAGB’s Michelle Riddalls

Aug 13 2019

Additional Topics

Germany Europe Advisory Committees Drug Review FDA Ingredients Innovation Market Access Market Intelligence OTC Drugs Politics Prescription To OTC Switch Regulation Consumer

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.